Tag: BPMX

Blue Horseshoe Stocks: USRM, TSLA Updates & More

U.S. Stem Cell, Inc. USRM

On Wednesday morning, we followed up with USRM after tracking it over a 289% rip subsequent to our alert on the play on February 27th. The stock had come down quite a bit off of those highs, and started to take on the appearance of a possible bottom-play. We mentioned the need to “return to monitoring this play more closely on the chance that it could be gearing up for another run.“

It did find its bottom and it most certainly was gearing up for another run, which took up the entirety of yesterday’s session. The stock traded in a range from .0181 to .03, for a solid intraday rip of 66%, nearly all of which was held into a strong close .0289.

That type of blatantly bullish activity warrants continued close observation of USRM as we close out the week.

Tesla, Inc. TSLA – Options Update

Just yesterday, we identified TSLA as being ripe for a recovery, citing the TSLA 04/07 $270-277.50 Calls as our targets of interest. It was another solid options trading idea for us, with every single set of contracts in the range providing opportunities for solid single-session gains.

$270 Calls – Range: 3.37-6.65 – Max Gain: 97%
$272.50 Calls – Range: 2.77-5.35 – Max Gain: 93%
$275 Calls – Range: 2.52-4.70 – Max Gain: 87%
$277.50 Calls – Range: 1.93-3.85 – Max Gain: 99%

We also could see more bullish activity out of these plays, which we chose to hopefully take advantage of a more extended-term recovery for TSLA.

_____

Fresh Options Ideas:

We’re  looking to ABDE on the heels of an earnings neat, and will be after some potential quick-strike gains out of the ADBE Weekly $125 and $130 Calls*.

After trending down a bit over the past week, SNAP has received an analyst downgrade, so we’ll want to radar the SNAP Weekly $20 Puts* today for potential intraday swing trades.

*DO NOT trade weekly options on a Friday unless you’re a highly experienced trader!

Extended Watchlist:
POTN, SFOR, ICNB, AREX, ZFGN, BPMX,

Blue Horseshoe Stocks: NUGT Options Recap & More

Direxion Daily Gold Miners Bull 3X ETF (NUGT)

NUGT has been on a fairly consistent rise for the past few weeks along with gold itself, and we were able to use the continuation of that trend to our extreme advantage yesterday.

We dropped a quick options idea for the NUGT Weekly $9-9.50 Calls into our watchlist, stipulating that we’d need to see a break of the 50DMA. We got what we were looking for, and the potential gains that followed were substantial.

$9 Calls – Range: .56-1.53 – Max Gain: 173%
$9.50 Calls – Range: .30-1.07 – Max Gain: 257%

Chat reminder: Also, we noticed the magnitude of the activity was going to allow for gains to made at higher increments, so we also suggested rolling up to the $10 Calls shortly after the open. Those ended up running 172% from from .25-.68.

We were just mentioning the benefits of our daily traders chats the other day, and here we have a fine example of why reading our premarket reports can be greatly augmented by participating in our in-session chats as well. Again, just send a Skype contact request to ‘stocksumo’ if you wish to join us!  Any of our readers are welcome!

TransEnterix Inc. TRXC – Insider Buying

We noticed a filing for a huge $5.2M insider position increase on TRXC at a price of 1.40, which coincides closely with recent relative lows, and isn’t too far above the stock’s annual low. We’ll be very interested to follow along with this stock after such a vote of confidence from an existing investor.  (>>View Filings)

Added Note: Speaking of insider trading plays, we also wanted to add a quick reminder on the one we submitted yesterday in STON. The stock made modest headway in continuing its established uptrend with a light 8% increase on the day, and will continue to be on our radars moving forward.

Immune Pharmaceuticals, Inc. IMNP

Additionally, we have a reminder to put out on IMNP, which we put on bottom-watch in our report dated December 27th. It took roughly a week of sideways trading for the stock to begin to perk its head up, but yesterday it began to gain some ground so we just wanted to remind readers that we still have this one on our viewscreens.

Extended Watchlist:
AMFE, GIGL, LIGA, GSAT, URRE, BPMX

Blue Horseshoe Stocks: IDXG Update & More

Interpace Diagnostics Group, Inc. IDXG

We tracked IDXG last week over a couple of stellar sessions that led to a swing of more than 400%, cautioning that a dip-and-rip could be in the cards after seeing such a volatile move to the upside.

That’s exactly what we’ve seen in the past couple of days, as IDXG came down to find support at the .865 level, and in the ensuing three sessions it’s been steadily registering higher highs and higher lows, getting back to 1.25 yesterday (+45%).

We’ll continue to follow this story, which kicked off with the revelation that Aetna would cover Interpace’s ThyraMir™ test for its 46 million insured members. (>>View PR)

Experience Art & Design, Inc. EXAD

We had EXAD tagged in yesterday’s premarket report and this subpenny play produced a moderate run to kick off the session, even as the larger markets were struggling with the Fed rate hike announcement.

From an early low of .0023, the stock took just the first hour of trading to find its way up to a high of .0038, for a 65% pop. IDXG hung around that level until around lunchtime, and it did come back down to its daily low toward the close, so we’ll be looking for the possibility of a rebound.

Catalyst Biosciences, Inc. CBIO

We’re also interested in following the activity of CBIO today, which is gapping up in the premarket to the tune of more than 100% and looks like it could be lining up to have a big day. We’ll want to make sure it holds above its 50DMA (.80) on any pullbacks, but if it can breach past its 200DMA of 1.31, things could get very interesting.

News broke yesterday via an 8-K filing that CBIO had entered into a definitive agreement with Wyeth LLC, (wholly-owned subsidiary of Pfizer Inc.) to transfer exclusive rights to research, develop, manufacture and commercialize Factor VIIa variants, CB 813a and CB 813d, as well as transferring the investigational NDA to CBIO as well. (>>View Filing)


Fresh Options Idea:  Transocean, Inc. RIG $15 and $14.50 Puts

Extended Watchlist:
VCEL, NWBO, BCLI, BPMX, DLOV, PPMT